New Wavelength-Dependent Indicators Improve Efficacy Of Spot-On Laser Treatment For Skin Blemishes: Study
- byDoctor News Daily Team
 - 10 July, 2025
 - 0 Comments
 - 0 Mins
 
                            
                                    Japan: An Osaka Metropolitan University-led research group has developed an index of the threshold energy density, known as fluence, and the dependent wavelength for picosecond lasers. This will help improve efficacy and reduce complications in people bothered by skin blemishes who might turn to laser treatment.
Picosecond lasers have in recent years been used to remove pigmented lesions.
These lasers deliver energy beams in pulses that last for about a trillionth of a second.
The lasers target melanosomes, which produce, store, and transport the melanin responsible for pigment.
Postdoctoral Fellow Yu Shimojo of OMU's Graduate School of Medicine and Specially Appointed Professor Toshiyuki Ozawa and Professor Daisuke Tsuruta of the school's Department of Dermatology were among the researchers who developed this first picosecond laser index for each of the wavelengths used in clinical practice in treating pigmented lesions.
The key findings of the study were as follows:
The threshold fluences were determined to be 0.95, 2.25, 2.75, and 6.50 J/cm² for 532-, 730-, 785-, and 1064-nm picosecond lasers, respectively.
The numerical results quantitatively revealed the relationship between irradiation wavelength, incident fluence, and spot size required to disrupt melanosomes distributed at different depths in the skin tissue.
The calculated irradiation parameters were consistent with clinical parameters that showed high efficacy with a low incidence of complications.
Comparing previously reported clinical studies, the researchers confirmed that clinical results showing low complication rates and high efficacy can be explained based on these wavelength-dependent indicators.
"The use of this indicator is expected to play an important part in setting irradiation conditions in clinical practice," Postdoc Fellow Shimojo said. "In addition, the implementation of picosecond laser therapy based on scientific evidence, rather than relying solely on physicians' experience, is expected to improve the safety and effectiveness of the treatment."
Reference:
Yu Shimojo, Takahiro Nishimura, Daisuke Tsuruta, Toshiyuki Ozawa, Henry Hin Lee Chan, Taro Kono. Wavelength‐dependent threshold fluences for melanosome disruption to evaluate the treatment of pigmented lesions with 532‐, 730‐, 755‐, 785‐, and 1064‐nm picosecond lasers. Lasers in Surgery and Medicine, 2024; DOI: 10.1002/lsm.23773.
                                
    Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
    The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
    Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
    If you come across any inconsistencies, please reach out to us at 
    admin@doctornewsdaily.com.
    We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
    By using this website, you agree to our 
    Terms of Use, 
    Privacy Policy, and 
    Advertisement Policy.
    For further details, please review our 
    Full Disclaimer.
Tags:
Recent News
Gum disease could silently cause serious brain dam...
- 03 November, 2025
 
Can Early-Day Fasting Significantly Boost Metaboli...
- 03 November, 2025
 
Delhi HC bars doctor from running medical centre d...
- 03 November, 2025
 
Phase III data for Gazyva/Gazyvaro show significan...
- 03 November, 2025
 
Daily Newsletter
Get all the top stories from Blogs to keep track.
                    
                    
0 Comments
Post a comment
No comments yet. Be the first to comment!